nach oben

Current Treatment Options in Psychiatry

Erschienen in:

01.12.2022 | PTSD (S Frankfurt, Section Editor)

Neuromodulation as an Augmenting Strategy for Behavioral Therapies for Anxiety and PTSD: a Narrative Review

verfasst von: Crystal Lantrip, PhD, Yvette Z. Szabo, PhD, F. Andrew Kozel, MD, Paul Holtzheimer, MD

Erschienen in: Current Treatment Options in Psychiatry | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Post-traumatic stress disorder (PTSD) is a prevalent problem. Despite current treatments, symptoms may persist, and neuromodulation therapies show great potential. A growing body of research suggests that transcranial magnetic stimulation (TMS) is effective as a standalone treatment for PTSD, with recent research demonstrating promising use when combined synergistically with behavioral treatments. In this review, we survey this literature including data suggesting mechanisms involved in anxiety and PTSD that may be targeted by neurostimulation.

Recent Findings

Evidence suggests the mechanism of action for TMS that contributes to behavioral change may be enhanced neural plasticity via increased functionality of prefrontal and subcortical/limbic structures and associated networks. Some research has demonstrated a behavioral change in PTSD and anxiety due to enhanced extinction learning or improved ability to think flexibly and reduce ruminative tendencies. Growing evidence suggests TMS may be best used as a therapeutic adjunct, at least acutely, for extinction-based exposure therapies in patients by accelerating therapy response.

Summary

While TMS has shown promise as a standalone intervention, augmentation with psychotherapy is one avenue of interest. Non-responders to current EBPs might particularly benefit from this sort of targeted approach, and it may shorten treatment length, which would help the successful completion of a course of therapy.

Kessler RC, Angermeyer M, Anthony JC, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization’s World Mental Health Survey Initiative. World Psychiatry. 2007;6(3):168–76.PubMedPubMedCentral

Resick PA, Galovski TE, Uhlmansiek MO, Scher CD, Clum GA, Young-Xu Y. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008;76(2):243–58. https://doi.org/10.1037/0022-006X.76.2.243.CrossRefPubMedPubMedCentral

Fulton JJ, Calhoun PS, Wagner HR, et al. The prevalence of posttraumatic stress disorder in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) veterans: a meta-analysis. J Anxiety Disord. 2015;31:98–107. https://doi.org/10.1016/j.janxdis.2015.02.003.CrossRefPubMed

Jacoby VM, Straud CL, Bagley JM, Tyler H, Baker SN, Denejkina A, Sippel LM, et al. Evidence-based posttraumatic stress disorder treatment in a community sample: military-affiliated versus civilian patient outcomes. J Trauma Stress. 2022. https://doi.org/10.1002/jts.22812.CrossRefPubMed

Litz BT, Berke DS, Kline NK, Grimm K, Rusowicz-Orazem L, Resick PA, Foa EB, et al. Patterns and predictors of change in trauma-focused treatments for war-related posttraumatic stress disorder. J Consult Clin Psychol. 2019;87(11):1019–29. https://doi.org/10.1037/ccp0000426.CrossRefPubMed

Tanielian, T. & Jaycox, L.H. (Eds.) (2008). Invisible wounds of war: psychological and cognitive injuries, their consequences, and services to assist recovery. Santa Monica, CA: RAND MG-720. 2008.

Gaynes BN, Lloyd SW, Lux L, et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. J Clin Psychiatry. 2014;75(5):477–489; quiz 489. https://doi.org/10.4088/JCP.13r08815.

Voelker R. Brain stimulation approved for obsessive-compulsive disorder. JAMA. 2018;320(11):1098–1098. https://doi.org/10.1001/jama.2018.13301.CrossRefPubMed

Karsen EF, Watts BV, Holtzheimer PE. Review of the effectiveness of transcranial magnetic stimulation for post-traumatic stress disorder. Brain Stimul. 2014;7(2):151–7. https://doi.org/10.1016/j.brs.2013.10.006.CrossRefPubMed

10.

Young JR, Galla JT, Appelbaum LG. Transcranial magnetic stimulation treatment for smoking cessation: an introduction for primary care clinicians. Am J Med. 2021;134(11):1339–43. https://doi.org/10.1016/j.amjmed.2021.06.037.CrossRefPubMedPubMedCentral

11.

Trevizol AP, Downar J, Vila-Rodriguez F, Konstantinou G, Daskalakis ZJ, Blumberger DM. Effect of repetitive transcranial magnetic stimulation on anxiety symptoms in patients with major depression: an analysis from the THREE-D trial. Depress Anxiety. 2021;38(3):262–71. https://doi.org/10.1002/da.23125.CrossRefPubMed

12.

• Cirillo P, Gold AK, Nardi AE, et al. Transcranial magnetic stimulation in anxiety and trauma-related disorders: a systematic review and meta-analysis. Brain Behav. 2019;9(6):e01284. https://doi.org/10.1002/brb3.1284. TMS is an effective treatment option for patients with medication-resistant depression, and a growing number of studies are evaluating the efficacy of TMS for other neuropsychiatric disorders such as anxiety and trauma-related disorders. In this meta-analysis, a review of the literature revealed that TMS has been more widely studied in PTSD than GAD. Overall, TMS demonstrated a large treatment effect for both PTSD and GAD.

13.

Madore MR, Kozel FA, Williams LM, Green LC, George MS, Holzheimer PE, Yesavage JA, Philip NS. Prefrontal transcranial magnetic stimulation for depression in US military veterans – a naturalistic cohort study in the Veterans Health Administration. J Affect Disord. 2022;297:671–8. https://doi.org/10.1016/j.jad.2021.10.025.CrossRefPubMed

14.

Iannone A, Cruz AP de M, Brasil-Neto JP, Boechat-Barros R. Transcranial magnetic stimulation and transcranial direct current stimulation appear to be safe neuromodulatory techniques useful in the treatment of anxiety disorders and other neuropsychiatric disorders. Arq Neuropsiquiatr. 2016;74(10):829–835. https://doi.org/10.1590/0004-282X20160115.

15.

Miniussi C, Cappa SF, Cohen LG, et al. Efficacy of repetitive transcranial magnetic stimulation/transcranial direct current stimulation in cognitive neurorehabilitation. Brain Stimul. 2008;1(4):326–36. https://doi.org/10.1016/j.brs.2008.07.002.CrossRefPubMed

16.

Nitsche MA, Cohen LG, Wassermann EM, et al. Transcranial direct current stimulation: state of the art 2008. Brain Stimul. 2008;1(3):206–23. https://doi.org/10.1016/j.brs.2008.06.004.CrossRefPubMed

17.

Sagliano L, Atripaldi D, De Vita D, D’Olimpio F, Trojano L. Non-invasive brain stimulation in generalized anxiety disorder: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 2019;93:31–8. https://doi.org/10.1016/j.pnpbp.2019.03.002.CrossRefPubMed

18.

Levi D, Vignati S, Guida E, et al. Tailored repetitive transcranial magnetic stimulation for depression and addictions. Prog Brain Res. 2022;270(1):105–21. https://doi.org/10.1016/bs.pbr.2022.01.024.CrossRefPubMed

19.

Müller-Dahlhaus F, Ziemann U. Metaplasticity in human cortex. Neuroscientist. 2015;21(2):185–202. https://doi.org/10.1177/1073858414526645.CrossRefPubMed

20.

Weise D, Mann J, Rumpf JJ, Hallermann S, Classen J. Differential regulation of human paired associative stimulation-induced and theta-burst stimulation-induced plasticity by L-type and T-type Ca2+ channels. Cereb Cortex. 2017;27(8):4010–21. https://doi.org/10.1093/cercor/bhw212.CrossRefPubMed

21.

Ruggiero RN, Rossignoli MT, Marques DB, et al. Neuromodulation of hippocampal-prefrontal cortical synaptic plasticity and functional connectivity: implications for neuropsychiatric disorders. Front Cell Neurosci. 2021;15. https://doi.org/10.3389/fncel.2021.732360.

22.

Milev RV, Giacobbe P, Kennedy SH, et al. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 4. Neurostimulation Treatments. Can J Psychiatry. 2016;61(9):561–75. https://doi.org/10.1177/0706743716660033.CrossRefPubMedPubMedCentral

23.

Lantrip C, Gunning FM, Flashman L, Roth RM, Holtzheimer PE. Effects of transcranial magnetic stimulation on the cognitive control of emotion: potential antidepressant mechanisms. J ECT. 2017;33(2):73–80. https://doi.org/10.1097/YCT.0000000000000386.CrossRefPubMed

24.

Greicius MD, Krasnow B, Reiss AL, Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci - PNAS. 2003;100(1):253–8. https://doi.org/10.1073/pnas.0135058100.CrossRefPubMed

25.

Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci. 2005;102(27):9673–8. https://doi.org/10.1073/pnas.0504136102.CrossRefPubMedPubMedCentral

26.

Fransson P. Spontaneous low-frequency BOLD signal fluctuations: an fMRI investigation of the resting-state default mode of brain function hypothesis. Hum Brain Mapp. 2005;26(1):15–29. https://doi.org/10.1002/hbm.20113.CrossRefPubMedPubMedCentral

27.

Kelly AMC, Uddin LQ, Biswal BB, Castellanos FX, Milham MP. Competition between functional brain networks mediates behavioral variability. Neuroimage. 2008;39(1):527–37. https://doi.org/10.1016/j.neuroimage.2007.08.008.CrossRefPubMed

28.

Whitfield-Gabrieli S, Thermenos HW, Milanovic S, et al. Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci U S A. 2009;106(4):1279–84. https://doi.org/10.1073/pnas.0809141106.CrossRefPubMedPubMedCentral

29.

Hampson M, Driesen N, Roth JK, Gore JC, Constable RT. Functional connectivity between task-positive and task-negative brain areas and its relation to working memory performance. Magn Reson Imaging. 2010;28(8):1051–7. https://doi.org/10.1016/j.mri.2010.03.021.CrossRefPubMedPubMedCentral

30.

Sheline YI, Barch DM, Price JL, et al. The default mode network and self-referential processes in depression. Proc Natl Acad Sci U S A. 2009;106(6):1942–7. https://doi.org/10.1073/pnas.0812686106.CrossRefPubMedPubMedCentral

31.

Zhao XH, Wang PJ, Li CB, et al. Altered default mode network activity in patient with anxiety disorders: an fMRI study. Eur J Radiol. 2007;63(3):373–8. https://doi.org/10.1016/j.ejrad.2007.02.006.CrossRefPubMed

32.

Northoff G. Anxiety disorders and the brain’s resting state networks: from altered spatiotemporal synchronization to psychopathological symptoms. Adv Exp Med Biol. 2020;1191:71–90. https://doi.org/10.1007/978-981-32-9705-0_5.CrossRefPubMed

33.

Miles SR, Menefee DS, Wanner J, Teten Tharp A, Kent TA. The relationship between emotion dysregulation and impulsive aggression in veterans with posttraumatic stress disorder symptoms. J Interpers Violence. 2016;31(10):1795–816. https://doi.org/10.1177/0886260515570746.CrossRefPubMed

34.

Szabo YZ, Warnecke AJ, Newton TL, Valentine JC. Rumination and posttraumatic stress symptoms in trauma-exposed adults: a systematic review and meta-analysis. Anxiety Stress Coping. 2017;30(4):396–414. https://doi.org/10.1080/10615806.2017.1313835.CrossRefPubMed

35.

Liston C, Chen AC, Zebley BD, et al. Default mode network mechanisms of transcranial magnetic stimulation in depression. Biol Psychiatry. 2014;76(7):517–26. https://doi.org/10.1016/j.biopsych.2014.01.023.CrossRefPubMedPubMedCentral

36.

Helpman L., Marin M-F, et al. Neural changes in extinction recall following prolonged exposure treatment for PTSD: a longitudinal fMRI study. Neuroimage Clin. 2016;12:715–723. https://doi.org/10.1016/j.nicl.2016.10.007.

37.

Smith NB, Doran JM, Sippel LM, Harpaz-Rotem I. Fear extinction and memory reconsolidation as critical components in behavioral treatment for posttraumatic stress disorder and potential augmentation of these processes. Neurosci Lett. 2017;649:170–5. https://doi.org/10.1016/j.neulet.2017.01.006.CrossRefPubMed

38.

Hoge CW, Grossman SH, Auchterlonie JL, Riviere LA, Milliken CS, Wilk JE. PTSD Treatment for soldiers after combat deployment: low utilization of mental health care and reasons for dropout. PS. 2014;65(8):997–1004. https://doi.org/10.1176/appi.ps.201300307.CrossRef

39.

• Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J Affect Disord. 2018;229:506–514. https://doi.org/10.1016/j.jad.2017.12.046. The findings of the RCT in veterans with PTSD demonstrated that TMS is effective for augmenting the effects of cognitive processing therapy (CPT), a widely used exposure-based psychotherapy, immediately after a course of CPT plus TMS and at follow-up several months later. These findings are important given that PTSD symptoms persist for some patients after completing a course of CPT, and TMS may offer a way to augment symptom improvement.

40.

Bouton ME. Context, ambiguity, and unlearning: sources of relapse after behavioral extinction. Biol Psychiatry. 2002;52(10):976–86. https://doi.org/10.1016/s0006-3223(02)01546-9.CrossRefPubMed

41.

Foa EB. Psychosocial therapy for posttraumatic stress disorder. J Clin Psychiatry. 2006;67(Suppl 2):40–5.PubMed

42.

Faucher CR, Doherty RA, Philip NS, Harle ASM, Cole JJE, Van’t Wout-Frank M. Is there a neuroscience-based, mechanistic rationale for transcranial direct current stimulation as an adjunct treatment for posttraumatic stress disorder? Behav Neurosci. 2021;135(6):702–713. https://doi.org/10.1037/bne0000487.

43.

Guhn A, Dresler T, Andreatta M, et al. Medial prefrontal cortex stimulation modulates the processing of conditioned fear. Front Behav Neurosci. 2014;8:44. https://doi.org/10.3389/fnbeh.2014.00044.CrossRefPubMedPubMedCentral

44.

Quirk GJ, Mueller D. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology. 2008;33(1):56–72. https://doi.org/10.1038/sj.npp.1301555.CrossRefPubMed

45.

Phelps EA, Delgado MR, Nearing KI, LeDoux JE. Extinction learning in humans: role of the amygdala and vmPFC. Neuron. 2004;43(6):897–905. https://doi.org/10.1016/j.neuron.2004.08.042.CrossRefPubMed

46.

Kalisch R, Korenfeld E, Stephan KE, Weiskopf N, Seymour B, Dolan RJ. Context-dependent human extinction memory is mediated by a ventromedial prefrontal and hippocampal network. J Neurosci. 2006;26(37):9503–11.CrossRefPubMedPubMedCentral

47.

Herrmann MJ, Katzorke A, Busch Y, et al. Medial prefrontal cortex stimulation accelerates therapy response of exposure therapy in acrophobia. Brain Stimul. 2017;10(2):291–7. https://doi.org/10.1016/j.brs.2016.11.007.CrossRefPubMed

48.

Gross JJ. Antecedent- and response-focused emotion regulation: divergent consequences for experience, expression, and physiology. J Pers Soc Psychol. 1998;74(1):224–37. https://doi.org/10.1037/0022-3514.74.1.224.CrossRefPubMed

49.

Vanderhasselt MA, De Raedt R, Brunoni AR, et al. tDCS over the left prefrontal cortex enhances cognitive control for positive affective stimuli. PLoS ONE. 2013;8(5):e62219–e62219. https://doi.org/10.1371/journal.pone.0062219.CrossRefPubMedPubMedCentral

50.

Liston C, McEwen BS, Casey BJ. Psychosocial stress reversibly disrupts prefrontal processing and attentional control. Proc Natl Acad Sci U S A. 2009;106(3):912–7. https://doi.org/10.1073/pnas.0807041106.CrossRefPubMedPubMedCentral

51.

Smith JM, Alloy LB. A roadmap to rumination: a review of the definition, assessment, and conceptualization of this multifaceted construct. Clin Psychol Rev. 2009;29(2):116–28. https://doi.org/10.1016/j.cpr.2008.10.003.CrossRefPubMed

52.

Nolen-Hoeksema S. The role of rumination in depressive disorders and mixed anxiety/depressive symptoms. J Abnorm Psychol. 2000;109(3):504–11.CrossRefPubMed

53.

McLaughlin KA, Nolen-Hoeksema S. Rumination as a transdiagnostic factor in depression and anxiety. Behav Res Ther. 2011;49(3):186–93. https://doi.org/10.1016/j.brat.2010.12.006.CrossRefPubMed

54.

Watkins ER, Roberts H. Reflecting on rumination: consequences, causes, mechanisms and treatment of rumination. Behav Res Ther. 2020;127:103573. https://doi.org/10.1016/j.brat.2020.103573.CrossRefPubMed

55.

Szabo YZ, Nelson SM, Lantrip C. Cognitive complaints in neuropsychologically normal adults: a brief report on the roles of childhood abuse and rumination. Traumatology. 2020;26(1):29–34. https://doi.org/10.1037/trm0000209.CrossRef

56.

Zhou HX, Chen X, Shen YQ, et al. Rumination and the default mode network: meta-analysis of brain imaging studies and implications for depression. Neuroimage. 2020;206:116287. https://doi.org/10.1016/j.neuroimage.2019.116287.CrossRefPubMed

57.

Mohan A, Roberto AJ, Mohan A, et al. The significance of the default mode network (DMN) in neurological and neuropsychiatric disorders: a review. Yale J Biol Med. 2016;89(1):49–57.PubMedPubMedCentral

58.

Marsland AL, Kuan DCH, Sheu LK, et al. Systemic inflammation and resting state connectivity of the default mode network. Brain Behav Immun. 2017;62:162–70. https://doi.org/10.1016/j.bbi.2017.01.013.CrossRefPubMedPubMedCentral

59.

De Raedt R, Leyman L, Baeken C, et al. Neurocognitive effects of HF-rTMS over the dorsolateral prefrontal cortex on the attentional processing of emotional information in healthy women: an event-related fMRI study. Biol Psychol. 2010;85(3):487–95. https://doi.org/10.1016/j.biopsycho.2010.09.015.CrossRefPubMed

60.

Baeken C, Marinazzo D, Wu GR, et al. Accelerated HF-rTMS in treatment-resistant unipolar depression: insights from subgenual anterior cingulate functional connectivity. World J Biol Psychiatry. 2014;15(4):286–97. https://doi.org/10.3109/15622975.2013.872295.CrossRefPubMed

61.

Baeken C, Van Schuerbeek P, De Raedt R, et al. The effect of one left-sided dorsolateral prefrontal sham-controlled HF-rTMS session on approach and withdrawal related emotional neuronal processes. Clin Neurophysiol. 2011;122(11):2217–26. https://doi.org/10.1016/j.clinph.2011.04.009.CrossRefPubMed

62.

Lantrip C, Delaloye S, Baird L, et al. Effects of left versus right dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation on affective flexibility in healthy women: a pilot study. Cogn Behav Neurol. 2019;32(2):69–75. https://doi.org/10.1097/WNN.0000000000000190.CrossRefPubMed

63.

De Witte S, Baeken C, Pulopulos MM, et al. The effect of neurostimulation applied to the left dorsolateral prefrontal cortex on post-stress adaptation as a function of depressive brooding. Prog Neuropsychopharmacol Biol Psychiatry. 2020;96:109687. https://doi.org/10.1016/j.pnpbp.2019.109687.CrossRefPubMed

64.

Spencer RL, Deak T. A users guide to HPA axis research. Phys Behav. 2017;178:43–65. https://doi.org/10.1016/j.physbeh.2016.11.014.CrossRef

65.

Post A, Keck ME. Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms? J Psychiatric Res. Published online 2001:23.

66.

Hedges DW, Massari C, Salyer DL, et al. Duration of transcranial magnetic stimulation effects on the neuroendocrine stress response and coping behavior of adult male rats. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(4):633–8. https://doi.org/10.1016/S0278-5846(03)00052-6.CrossRefPubMed

67.

Ray RD, Zald DH. Anatomical insights into the interaction of emotion and cognition in the prefrontal cortex. Neurosci Biobehav Rev. 2012;36(1):479–501. https://doi.org/10.1016/j.neubiorev.2011.08.005.CrossRefPubMed

68.

Jankord R, Herman JP. Limbic regulation of hypothalamo-pituitary-adrenocortical function during acute and chronic stress. Ann N Y Acad Sci. 2008;1148:64–73. https://doi.org/10.1196/annals.1410.012.CrossRefPubMedPubMedCentral

69.

Dedovic K, Duchesne A, Andrews J, Engert V, Pruessner JC. The brain and the stress axis: the neural correlates of cortisol regulation in response to stress. Neuroimage. 2009;47(3):864–71. https://doi.org/10.1016/j.neuroimage.2009.05.074.CrossRefPubMed

70.

Baeken C, De Raedt R, Van Schuerbeek P, et al. Right prefrontal HF-rTMS attenuates right amygdala processing of negatively valenced emotional stimuli in healthy females. Behav Brain Res. 2010;214(2):450–5. https://doi.org/10.1016/j.bbr.2010.06.029.CrossRefPubMed

71.

George MS, Wassermann EM, Williams WA, et al. Changes in mood and hormone levels after rapid-rate transcranial magnetic stimulation (rTMS) of the prefrontal cortex. J Neuropsychiatry Clin Neurosci. 1996;8(2):172–80. https://doi.org/10.1176/jnp.8.2.172.CrossRefPubMed

72.

Evers S, Hengst K, Pecuch PW. The impact of repetitive transcranial magnetic stimulation on pituitary hormone levels and cortisol in healthy subjects. J Affect Disord. 2001;66(1):83–8. https://doi.org/10.1016/s0165-0327(00)00289-5.CrossRefPubMed

73.

Szeszko PR, Lehrner A, Yehuda R. Glucocorticoids and hippocampal structure and function in PTSD. Harv Rev Psychiatry. 2018;26(3):142–57. https://doi.org/10.1097/HRP.0000000000000188.CrossRefPubMed

74.

Meewisse ML, Reitsma JB, de Vries GJ, Gersons BP, Olff M. Cortisol and post-traumatic stress disorder in adults: systematic review and meta-analysis. Br J Psychiatry. 2007;191:387–92. https://doi.org/10.1192/bjp.bp.106.024877.CrossRefPubMed

75.

Lehrner A, Hildebrandt T, Bierer LM, et al. A randomized, double-blind, placebo-controlled trial of hydrocortisone augmentation of prolonged exposure for PTSD in U.S. combat veterans. Behav Res Ther. 2021;144:103924. https://doi.org/10.1016/j.brat.2021.103924.

76.

Lindqvist D, Dhabhar FS, James SJ, et al. Oxidative stress, inflammation and treatment response in major depression. Psychoneuroendocrinology. 2017;76:197–205. https://doi.org/10.1016/j.psyneuen.2016.11.031.CrossRefPubMed

77.

Passos IC, Vasconcelos-Moreno MP, Costa LG, et al. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry. 2015;2(11):1002–12. https://doi.org/10.1016/S2215-0366(15)00309-0.CrossRefPubMed

78.

Michopoulos V, Powers A, Gillespie CF, Ressler KJ, Jovanovic T. Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology. 2017;42(1):254–70. https://doi.org/10.1038/npp.2016.146.CrossRefPubMed

79.

Tian L, Sun SS, Cui LB, et al. Repetitive transcranial magnetic stimulation elicits antidepressant- and anxiolytic-like effect via nuclear factor-E2-related factor 2-mediated anti-inflammation mechanism in rats. Neuroscience. 2020;429:119–33. https://doi.org/10.1016/j.neuroscience.2019.12.025.CrossRefPubMed

80.

Phan KL, Wager T, Taylor SF, Liberzon I. Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage. 2002;16(2):331–48. https://doi.org/10.1006/nimg.2002.1087.CrossRefPubMed

81.

Quaedflieg CWEM, Meyer T, Smulders FTY, Smeets T. The functional role of individual-alpha based frontal asymmetry in stress responding. Biol Psychol. 2015;104:75–81. https://doi.org/10.1016/j.biopsycho.2014.11.014.CrossRefPubMed

82.

De Raedt R, Koster EHW. Understanding vulnerability for depression from a cognitive neuroscience perspective: a reappraisal of attentional factors and a new conceptual framework. Cogn Affect Behav Neurosci. 2010;10(1):50–70. https://doi.org/10.3758/CABN.10.1.50.CrossRefPubMed

83.

Arnsten AFT. Stress weakens prefrontal networks: molecular insults to higher cognition. Nat Neurosci. 2015;18(10):1376–85. https://doi.org/10.1038/nn.4087.CrossRefPubMedPubMedCentral

84.

O’Donnell ML, Lau W, Chisholm K, Agathos J, Little J, Terhaag S, Brand R, et al. A pilot study of the efficacy of the unified protocol for transdiagnostic treatment of emotional disorders in treating posttraumatic psychopathology: a randomized controlled trial. J Trauma Stress. 2021;34(3):563–74. https://doi.org/10.1002/jts.22650.CrossRefPubMed

85.

Foa E, Hembree EA, Rothbaum BO, Rauch S. Prolonged exposure therapy for PTSD: emotional processing of traumatic experiences – therapist guide. 2nd ed. New York: Oxford University Press; 2019.CrossRef

86.

Isserles M, Shalev AY, Roth Y, et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder – a pilot study. Brain Stimul. 2013;6(3):377–83. https://doi.org/10.1016/j.brs.2012.07.008.CrossRefPubMed

87.

• Isserles M, Tendler A, Roth Y, et al. Deep transcranial magnetic stimulation combined with brief exposure for posttraumatic stress disorder: a prospective multisite randomized trial. Biol Psychiatry. 2021;90(10):721–728. https://doi.org/10.1016/j.biopsych.2021.04.019. The findings of the RCT demonstrated that the order of treatment when using TMS to augment the effect of behavior therapy is likely important in PTSD. This experimental paradigm first administered the behavioral exposure, then administered deep TMS. They found that both the control and active conditions improved, but the control group experienced statistically superior improvement.

Titel: Neuromodulation as an Augmenting Strategy for Behavioral Therapies for Anxiety and PTSD: a Narrative Review
verfasst von: Crystal Lantrip, PhD
Yvette Z. Szabo, PhD
F. Andrew Kozel, MD
Paul Holtzheimer, MD
Publikationsdatum: 01.12.2022
Verlag: Springer International Publishing
Erschienen in: Current Treatment Options in Psychiatry / Ausgabe 4/2022
Elektronische ISSN: 2196-3061
DOI: https://doi.org/10.1007/s40501-022-00279-x

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Neuromodulation as an Augmenting Strategy for Behavioral Therapies for Anxiety and PTSD: a Narrative Review